期刊文献+

SFRP2与Periostin的相互作用在瘢痕疙瘩形成机制中的研究 被引量:1

Experimental Study of Interaction between SERP 2 and Periostin in the Formation of Keloid
下载PDF
导出
摘要 目的利用pull-down技术验证凋亡相关蛋白基因SFRP2(Secreted frizzled-related protein2)和骨母细胞特异性因子-2Periostin(Osteoblast-specific factor2)间的相互作用。方法构建能在哺乳动物细胞中表达带HA标签的Periostin融合蛋白(HA-Periostin)的重组载体pCMV-HA-Periostin,经酶切鉴定正确后,和表达带Myc标签的融合蛋白(Myc-SFRP2)的重组真核表达载体pCMV-HA-SFRP2,单独或共转染人293细胞,利用pull-down技术验证Periostin与SFRP2间的相互作用。结果成功构建重组载体pCMV-HA-Periostin,与抗Myc单克隆抗体沉淀Myc-SFRP2相互作用蛋白复合物后,可以检测到HA-Periostin的表达。通过体外蛋白质结合实验证实了Periostin与SFRP2间的相互作用。结论成功构建带HA标签的Periostin融合蛋白(HA-Periostin)的重组载体,利用pull-down技术证实了Periostin与SFRP2间的存在相互作用。 Objective To investigate the interaction between Periostin (osteoblast-specifie factor 2) and SFRP 2 (Secreted frizzled-related protein 2) in the formation of keloid. Methods HA-tagged fusion protein (HA- Periostin) expression vector was constructed, identified and transfected into human embryo kidney 293 (HEK293) cells alone or with Myc-tagged fusion protein (Myc-SFRP 2) expression vector pMCV-Myc-SFRP 2. The interaction between SFRP 2 and Periostin was detected by pull-down technique. Results Double restriction enzyme digestion showed that pCMV-HA-Periostin was constructed successfully. When Myc-SFRP 2 was immunoprecipitanted, HA- Periostin was identified. And the interaction between SFRP 2 and Periostin was found by GST pull-down and His pull-down technique. Conclusion The recombinant vector pCMV-HA- Periostin was constructed successfully. The interaction between SFRP 2 and Periostin could be identified by GST pull-down and His pull-down.
出处 《组织工程与重建外科杂志》 2009年第4期199-201,207,共4页 Journal of Tissue Engineering and Reconstructive Surgery
基金 国家重点基础研究发展规划项目(G1999054204)
关键词 凋亡相关蛋白基因 骨母细胞特异性因子-2 相互作用 Secreted frizzled-related protein 2 Periostin Interaction
  • 相关文献

参考文献1

二级参考文献15

  • 1Hough S R, Clements I, Welch P J, et al. Differentiation of mouse embryonic stem cells after RNA interference-mediated silencing of OCT4 and Nanog[J]. Stem Cells, 2006,24:1467-1475.
  • 2Hyslop L, Stojkovic M, Armstrong L, et al. Downregulation of NANOG induces differentiation of human embryonic stem cells to extraembryonic lineages[J]. Stem Cells, 2005,23:1035-1043.
  • 3Mitsui K, Tokuzawa Y, Itoh H, et al. The homeoprotein Nanog is required for maintenance of pluripotency in mouse epiblast and ES cells[J]. Cell, 2003,113(5):631-642.
  • 4Darr H, Mayshar Y, Benvenisty N. Overexpression of NANOG in human ES cells enables feeder-free growth while inducing primitive ectoderm features[J]. Development, 2006,133:1193-1201.
  • 5Chambers I, Colby D, Robertson M, et al. Functional expression cloning of NANOG, a pluripotency sustaining factor in embryonic stem cells[J]. Cell, 2003,113:643-655.
  • 6Ezeh U I, Turek P J, Reijo R A, et al. Human embryonic stem cell genes OCT4, NANOG, STELLAR,and GDF3 are expressed in both seminoma and breast carcinoma [J]. Cancer, 2005,104:2255- 2265.
  • 7Nakayama K, Nakayama N, Davidson B, et al. A BTB/POZ protein, NAC-1, is related to tumor recurrence and is essential for tumor growth and survival[J]. Proc Natl Aead Sci USA, 2006,103 (49): 18739-18744.
  • 8Wang J, Rao S, Chu J, et al. A protein interaction network for plufipotency of embryonic stem cells [J]. Nature, 2006,444(7117): 364-368.
  • 9Smith A G, Heath J K, Donaldson D D, et al. Inhibition of pluripotential embryonic stem cell differentiation by purified polypeptides[J]. Nature, 1988,336:688-690.
  • 10Daheron L, Opitz S L, Zaehres H, et al. LIF/STAT3 signaling fails to maintain self-renewal of human embryonic stem cells [J]. Stem Cells, 2004,22:770-778.

同被引文献1

引证文献1

二级引证文献3

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部